{"DataElement":{"publicId":"2551872","version":"1","preferredName":"Breast Tumor Microscopic Finding","preferredDefinition":"Text terms to capture microscopic and diagnostic patterns of breast tumor(s).","longName":"BRSTCA_MICRO_FNG_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2188683","version":"1","preferredName":"Breast Tumor Histologic Description","preferredDefinition":"information related to the histologic description of a breast tumor.","longName":"BRST_TUMOR_HIST_DESC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207295","version":"1","preferredName":"Histologic Description ","preferredDefinition":"Of or relating to histology.:Description; a statement that represents something in words.","longName":"C25526:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1F1E-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E53AD652-1591-2EF1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2551870","version":"1","preferredName":"Breast Carcinoma Microscopic Finding","preferredDefinition":"Text terms to identify microscopic and diagnostic patterns in breast cancer.","longName":"BRSTCA_MICRO_FNG_TP","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"28","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Papilloma","valueDescription":"Papilloma","ValueMeaning":{"publicId":"2575025","version":"1","preferredName":"Papilloma","longName":"2575025","preferredDefinition":"Papilloma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F21E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-23","modifiedBy":"REEVESD","dateModified":"2005-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2407C0D2-9028-14C1-E044-0003BA3F9857","beginDate":"2006-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2006-12-07","deletedIndicator":"No"},{"value":"Radial scar","valueDescription":"RADIAL SCAR","ValueMeaning":{"publicId":"2566481","version":"1","preferredName":"RADIAL SCAR","longName":"2566481","preferredDefinition":"RADIAL SCAR","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radial Scar/Complex Sclerosing Lesion","conceptCode":"C9495","definition":"A benign breast lesion characterized by the presence of fibrosis with stellate appearance in the parenchyma.  The lesions are often multiple and bilateral.  Grossly, the lesions are irregular and firm and resemble carcinoma.  Microscopically, the stellate lesions are composed of dense, hyalinized collagen.  Entrapped in the collagen are tubules.  There is no evidence of cytologic atypia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0BE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2407C0D2-9034-14C1-E044-0003BA3F9857","beginDate":"2006-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2006-12-07","deletedIndicator":"No"},{"value":"Invasive cancer","valueDescription":"INVASIVE CANCER","ValueMeaning":{"publicId":"2563709","version":"1","preferredName":"INVASIVE CANCER","longName":"2563709","preferredDefinition":"INVASIVE CANCER","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C5EA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-06","endDate":null,"createdBy":"CVALMONT","dateCreated":"2002-12-06","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2407C0D2-9040-14C1-E044-0003BA3F9857","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2006-12-07","deletedIndicator":"No"},{"value":"DCIS","valueDescription":"Ductal carcinoma in situ","ValueMeaning":{"publicId":"2575870","version":"1","preferredName":"Ductal carcinoma in situ","longName":"2575870v1.00","preferredDefinition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Ductal Carcinoma In Situ","conceptCode":"C2924","definition":"A breast carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F56B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-01","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2407C0D2-904C-14C1-E044-0003BA3F9857","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2006-12-07","deletedIndicator":"No"},{"value":"LVI","valueDescription":"Lymphovascular Invasion","ValueMeaning":{"publicId":"2574980","version":"1","preferredName":"Lymphovascular Invasion","longName":"2574980","preferredDefinition":"Lymphovascular Invasion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F1F1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-20","modifiedBy":"REEVESD","dateModified":"2005-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2407C0D2-9058-14C1-E044-0003BA3F9857","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2006-12-07","deletedIndicator":"No"},{"value":"Benign","valueDescription":"Benign","ValueMeaning":{"publicId":"2558281","version":"1","preferredName":"Benign","longName":"2558281","preferredDefinition":"(beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign","conceptCode":"C14172","definition":"For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B0B6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2407C0D2-9064-14C1-E044-0003BA3F9857","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2006-12-07","deletedIndicator":"No"},{"value":"Sclerosing lesion","valueDescription":"Sclerosing lesion","ValueMeaning":{"publicId":"2582354","version":"1","preferredName":"Sclerosing lesion","longName":"2582354","preferredDefinition":"Sclerosing lesion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0EBF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2006-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2407C0D2-9070-14C1-E044-0003BA3F9857","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2006-12-07","deletedIndicator":"No"},{"value":"Adenosis","valueDescription":"Adenosis","ValueMeaning":{"publicId":"2580329","version":"1","preferredName":"Adenosis","longName":"2580329","preferredDefinition":"A non-neoplastic disorder characterized by epithelial and/or myoepithelial tissue growth in the breast lobules.  It may be associated with apocrine changes or sclerosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Adenosis","conceptCode":"C3484","definition":"A non-neoplastic disorder characterized by epithelial and/or myoepithelial tissue growth in the breast lobules.  It may be associated with apocrine changes or sclerosis.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-06D6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-07-27","modifiedBy":"REEVESD","dateModified":"2012-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2407C0D2-907C-14C1-E044-0003BA3F9857","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2006-12-07","deletedIndicator":"No"},{"value":"Tumor stromal bed","valueDescription":"Tumor stromal bed","ValueMeaning":{"publicId":"2582355","version":"1","preferredName":"Tumor stromal bed","longName":"2582355","preferredDefinition":"Tumor stromal bed","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0EC0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2006-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2407C0D2-9088-14C1-E044-0003BA3F9857","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2006-12-07","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B7ABDE8-D563-013D-E044-0003BA3F9857","beginDate":"2007-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-03-12","modifiedBy":"REEVESD","dateModified":"2007-03-12","deletedIndicator":"No"},{"value":"Fibroadenoma","valueDescription":"Fibroadenoma","ValueMeaning":{"publicId":"2566468","version":"1","preferredName":"Fibroadenoma","longName":"2566468","preferredDefinition":"This is the most common benign breast lesion.  It usually occurs in premenopausal women.  Diagnostic exams and procedures include: clinical exam, imaging (mammography and ultra sound), and tissue biopsy (fine-needle aspiration or core biopsy). -2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Fibroadenoma","conceptCode":"C3744","definition":"A benign tumor of the breast characterized by the presence of stromal and epithelial elements. It presents as a painless, solitary, slow growing, firm, and mobile mass. It is the most common benign breast lesion. It usually occurs in women of childbearing age. The majority of fibroadenomas do not recur after complete excision. A slightly increased risk of developing cancer within fibroadenomas or in the breast tissue of patients previously treated for fibroadenomas has been reported.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0B1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B7ABDE8-D56F-013D-E044-0003BA3F9857","beginDate":"2007-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-03-12","modifiedBy":"REEVESD","dateModified":"2007-03-12","deletedIndicator":"No"},{"value":"LCIS","valueDescription":"Lobular Breast Carcinoma In Situ","ValueMeaning":{"publicId":"2581227","version":"1","preferredName":"Lobular Breast Carcinoma In Situ","longName":"2581227","preferredDefinition":"Lobular carcinoma in situ is characterized by a proliferation of monomorphic cells completely filling the lumina. The overall lobular architecture is preserved. LCIS is frequently multifocal (90% in some series) and bilateral. LCIS seldom becomes invasive, however there is an increased risk of infiltrating ductal adenocarcinoma.  --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Lobular Carcinoma In Situ","conceptCode":"C4018","definition":"A non-invasive adenocarcinoma of the breast characterized by a proliferation of monomorphic cells completely filling the lumina.  The overall lobular architecture is preserved.  It is frequently multifocal (90% in some series) and bilateral.  It seldom becomes invasive; however there is an increased risk of infiltrating ductal adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A58-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2B7ABDE8-D57B-013D-E044-0003BA3F9857","beginDate":"2007-03-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-03-12","modifiedBy":"REEVESD","dateModified":"2007-03-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2551869","version":"1","preferredName":"Breast Carcinoma Microscopic Finding Type","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002:Microscopic; too small to be seen except under a microscope.:Clinical manifestations that can be either objective when observed by a physician, or subjective when perceived by the patient.:Type; a subdivision of a particular kind of thing.","longName":"C4872:C25252:C3367:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Microscopic","conceptCode":"C25252","definition":"Too small to be seen except under a microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2407BE57-F14A-1455-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"ONEDATA","dateModified":"2006-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2407BE57-F15B-1455-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2013-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2548333","version":"1","longName":"I-SPY","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812254","version":"1","longName":"C911/C1000","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Microscopic Findings","type":"Preferred Question Text","description":"Microscopic Findings","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2407BE57-F170-1455-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-12-07","modifiedBy":"REEVESD","dateModified":"2011-03-18","changeDescription":"Curated to support I-SPY CRF curation in C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}